Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology II Exam 1 > Hypnotic Agents > Flashcards

Hypnotic Agents Flashcards

(70 cards)

Start Studying
1
Q

Benzodiazepines (2nd generation GABA hypnotics) to know (3)

A

Flurazepam, temazepam, triazolam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non-benzodiazepine BZD agonists (3rd generation GABA hypnotics) to know (3)

A

Eszopiclone, zolpidem, zaleplon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Melatonin receptor agonists

A

Ramelteon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Orexin receptor antagonists (newest class)

A

Suvorexant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ultra-short hypnotics: half-life

A

2-3 H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ultra-short hypnotics use

A

Patients having trouble falling asleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Advantage of ultra-short hypnotics (half-life 2-3 H)

A

Little daytime drowsiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Disadvantages of ultra-short hypnotics (half-life 2-3 H)

A

Rebound insomnia and REM rebound in early morning, tendency to use higher doses to achieve longer DOA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Short hypnotics half-life

A

5+ H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Short hypnotics use

A

Patients wake up in the middle of the night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

4 advantages of short hypnotics

A
  • Does not accumulate in the body
  • low incidence of residual effects
  • not metabolized by CYPs
  • tolerance to hypnotic effect is slow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Disadvantage of short hypnotics

A

Rebound insomnia and REM rebound in early morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Long hypnotics half-life

A

24-120 H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Long hypnotics use

A

Patients wake up early in the morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

3 advantages to long hypnotics

A
  • Maybe more effective on the 2nd night
  • rebound insomnia and REM are less intense after DC
  • residual daytime anti-anxiety effects may be helpful
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2 disadvantages of long hypnotics

A
  • Residual daytime drowsiness (may be severe)

- potential for drug accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ultra-short acting BZ to know

A

Triazolam (half-life 1.5-5 H, eliminated in 12-15 H)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

1 good and 1 bad about triazolam

A
  • Low incidence of daytime drowsiness;

- rebound insomnia and REM rebound can occur in a single night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

**Incidence of anterograde amnesia is higher than with other hypnotics

A

Triazolam (ultra-short acting BZ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Short acting BZ to know

A

Temazepam (half-life 3-18 H)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why would temazepam be presented for use especially in elderly patients?

A

Eliminated by conjugation (Phase II processes fairly unaffected by age)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

2 good and 1 bad about temazepam

A
  • Little or no tolerance over 2 weeks
  • low incidence of daytime drowsiness
  • insomnia and REM rebound are possible (short acting BZ)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Long acting BZ to know

A

Flurazepam (half-life 2.3 H, but active metabolites have 74-90 H half lives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Residual anti-anxiety effect, maybe more effective on second night

A

Flurazepam (long acting BZ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
At what rate does tolerance develop to flurazepam?
Slowly (long acting BZ)
26
Describe the daytime drowsiness AND rebound insomnia/REM likeliness with flurazepam.
Causes daytime drowsiness, but rebound insomnia/REM is unlikely (long-acting BZ)
27
T/F: Non-benzodiazepine BZD receptor agonists are structurally distinct from BZDs and are allosteric agonists at a distinct region on the GABA-A receptor.
False- allosteric agonists are the BZD receptor on GABA-A
28
Selectivity of non-BZ BZD receptor agonists
Selective for GABAa receptors containing A1 subunits
29
What are non-BZ BZD receptor agonists actions limited to?
Hypnotic and amnestic effects (NO anti-anxiety, anti-seizure, muscle relaxation, affect on learning/memory NONE)
30
What are 3 similarities between zolpidem, eszopiclone, and zaleplon?
Considered ultra-short acting (half-lives 1.5-7 H), schedule IV, do not suppress REM or N3 sleep at therapeutic doses
31
Has no limitation of how long it can be used
Eszopiclone
32
How do non-BZ BZD agonists' ADEs compared to BZDs'?
Similar but frequency and severity may be less (actions limited to hypnotic and amnestic...)
33
Function: orexin A and orexin B - antagonist?
Hypothalamic neuropeptides that promote wakefulness and regulate the sleep-wake cycle - suvorexant
34
MOA of suvorexant
Block OX1R and OX2R receptors to prevent binding of orexins A and B
35
What DOA does suvorexant have?
Short acting (half-life 12 h)
36
ADE of suvorexant
Similar to other hypnotics, mild cataplexy (leg weakness/paralysis)
37
Use and schedule of suvorexant
New drug with unclear role in insomnia; CIV
38
Melatonin is a hormone involved in circadian rhythms and the sleep-awake cycle. How/where does it act?
Stimulates melatonin MT1 and MT2 GPCRs in the suprachiasmatic nucleus of the hypothalamus
39
MOA= agonist at MT1 receptors
Ramelteon
40
DOA of ramelteon
Ultra-short acting (half-life 1.5-5 H)
41
Use and schedule of ramelteon
Improves some sleep parameters but effect size is small, not controlled (melatonin for jet lag?)
42
ADE of ramelteon
Generally milder than BZDs (somnolence, dizziness)
43
When to use lower doses: (3)
- Patient is likely to use alcohol - elderly patients (avoid use if possible) - patients with hepatic or renal disease
44
How long should hypnotics be used for?
Used temporarily, avoid successive nightly therapy
45
When do you taper hypnotics off?
After chronic use (to avoid/deal with withdrawal)
46
Contraindications for hypnotics (4)
- Sleep apnea (heavy snoring) - history of alcohol or drug abuse - pregnancy - suicidal risk
47
Non-REM is what % of sleep?
50-60%
48
How is Non-REM sleep distinguished
increasing arousal threshold and slowing or cortical EEG
49
REM is what % of sleep?
20-25%
50
What occurs in REM?
rapid eye movements dreaming sleep muscle paralysis
51
The ascending arousal system is located where?
pons/hypothalamus
52
What does the ascending arousal system use?
NE, DA, 5-HT, H1, glutamate, Ach | also peptide orexin
53
Orexin is used for what?
reinforce and maintain wakefulness
54
sleep-promoting system is located where?
pre optic area/pons/hypothalamus
55
What does the sleep-promoting system use?
GABA to inhibit arousal system
56
Hormone involved in circadian rhythms and sleep-awake cycle
melatonin
57
definition of insomnia
inability to fall asleep difficulty remaining asleep waking too early happens despite adequate opportunity
58
Short term insomnia
lasts <3 weeks | related to identifiable stressor
59
Chronic insomnia
occurring >3 times per week, >3 months specific stressor not identifiable likely usually requires combo of behavioral therapy and hypnotics
60
Common causes of insomnia
- increase with age - poor sleep hygiene - meds/drugs - pain and other medical conditions - psychological stress
61
Medical conditions that could cause insomnia
sleep apnea | parkinsons
62
General approach to treating insomnia
- treat underlying disorder - counsel on sleep hygiene and stimulus control - behavioral therapy
63
Types of behavioral therapy for insomnia
relaxation sleep restriction cognitive therapy
64
Rationale for hypnotic therapy
- shorten sleep onset - prolong duration of sleep - reduce nocturnal wakefulness - improve daytime function
65
Effect of hypnotics on first night
- decrease sleep latency, lengthen duration - decrease awake time after sleep onset - decrease N3 and REM time - increase N2 sleep time
66
Effect of hypnotics with chronic use
- tolerance to hypnotic effect - REM returns to previous point - rebound insomnia upon discontinuation
67
Side effects common to all hypnotics
- residual daytime sleepiness, drowsiness, dizzy - cognitive impairment - sleeping while driving, cooking, sex, phone calls - suppress respiration that worsen in apnea - habit forming & rebound
68
Pregnancy and hypnotics
teratogenicity | neonatal dependency
69
Alcohol consumption and hypnotics
excessive sedation | respiratory depression
70
Geriatric patients and hypnotics
decreased renal/hepatic Cl a increased susceptibility to sedative effects risk of falls greatly increases

Pharmacology II Exam 1 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions